S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
Free Webinar | October 11: How to Break Barriers
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
Live Updates: Russia-Ukraine War
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Too Soon: 3 Reasons to Wait on DocuSign Stock
OPEC+ makes big oil cut to boost prices; pump costs may rise
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
Hot Potato: Lamb Weston Stock Confirms a Top 
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
Free Webinar | October 11: How to Break Barriers
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
Live Updates: Russia-Ukraine War
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Too Soon: 3 Reasons to Wait on DocuSign Stock
OPEC+ makes big oil cut to boost prices; pump costs may rise
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
Hot Potato: Lamb Weston Stock Confirms a Top 
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
Free Webinar | October 11: How to Break Barriers
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
Live Updates: Russia-Ukraine War
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Too Soon: 3 Reasons to Wait on DocuSign Stock
OPEC+ makes big oil cut to boost prices; pump costs may rise
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
Hot Potato: Lamb Weston Stock Confirms a Top 
S&P 500   3,783.28
DOW   30,273.87
QQQ   281.98
Free Webinar | October 11: How to Break Barriers
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Rivian Checks Off Boxes, But Still Needs a Lot to Go Right
Live Updates: Russia-Ukraine War
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
Too Soon: 3 Reasons to Wait on DocuSign Stock
OPEC+ makes big oil cut to boost prices; pump costs may rise
Move Over Lithium – 220 Pounds of Graphite In Every EV Battery (Ad)
3 Alzheimer Stocks to Buy as the Race for a Cure Heats Up
Hot Potato: Lamb Weston Stock Confirms a Top 
NASDAQ:ATXI

Avenue Therapeutics - ATXI News Today

$8.47
-6.03 (-41.59%)
(As of 10/5/2022 12:00 AM ET)
Add
Compare
Today's Range
$8.12
$10.50
50-Day Range
$3.21
$67.50
52-Week Range
$3.00
$27.75
Volume
2.70 million shs
Average Volume
7.04 million shs
Market Capitalization
$12.45 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Get Avenue Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATXI and its competitors with MarketBeat's FREE daily newsletter.



ATXI Media Mentions By Week

ATXI Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ATXI
News Sentiment

1.50

0.72

Average
Medical
News Sentiment

ATXI News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ATXI Articles
This Week

2

1

ATXI Articles
Average Week

SourceHeadline
marketwatch.com logoAvenue Therapeutics Shares Drop 34% After Public Offering Prices
marketwatch.com - October 5 at 3:47 PM
finance.yahoo.com logoUrica Therapeutics Appoints Seasoned Biotech Executive Jay D. Kranzler, M.D., Ph.D., as Chairman and Chief Executive Officer
finance.yahoo.com - October 3 at 11:04 AM
MarketBeat logoAvenue Therapeutics, Inc. (NASDAQ:ATXI) Short Interest Update
americanbankingnews.com - September 28 at 1:35 AM
marketwatch.com logoAvenue Therapeutics Shareas Surge 160%
marketwatch.com - September 27 at 4:38 PM
nasdaq.com logoAvenue Therapeutics Spikes 168%
nasdaq.com - September 27 at 11:37 AM
marketwatch.com logoAvenue Therapeutics Shares Continue Reverse-Stock Split Slide
marketwatch.com - September 26 at 2:43 PM
marketwatch.com logoAvenue Therapeutics Shares Down 38% After Reverse-Share Split
marketwatch.com - September 23 at 6:15 PM
markets.businessinsider.com logoAvenue Therapeutics Sinks 25%; Shares Start Trading After Reverse Stock Split
markets.businessinsider.com - September 23 at 1:14 PM
finance.yahoo.com logoAvenue Therapeutics Announces Reverse Stock Split, Regulatory Update For Lead Its Pain Candidate
finance.yahoo.com - September 23 at 1:14 PM
marketwatch.com logoAvenue Therapeutics Shares Rise After IV Tramadol Update, Reverse Split News
marketwatch.com - September 22 at 10:26 PM
seekingalpha.com logoAvenue Therapeutics up 4% on 1-for-15 reverse stock split
seekingalpha.com - September 22 at 10:26 PM
finance.yahoo.com logoAvenue Therapeutics Announces Reverse Stock Split and Provides Regulatory Update for IV Tramadol Including Receipt of Type A Meeting Minutes from the FDA
finance.yahoo.com - September 22 at 10:26 PM
msn.com logoTake a look inside the new Avenue Pub space in downtown Tuscaloosa: ‘This is a long-term investment’
msn.com - September 7 at 7:47 AM
nypost.com logoMadison Avenue retail shows signs of life with six new stores
nypost.com - September 5 at 3:26 PM
msn.com logo1 dead, multiple others hurt after multi-vehicle crash on I-75 south at Cleveland Avenue, APD says
msn.com - September 5 at 12:23 AM
msn.com logoBREAKING: Police at possible barricade situation near Druid Hill Avenue in Baltimore
msn.com - June 29 at 8:54 AM
msn.com logoSaks Fifth Avenue closing Downtown Cincinnati location
msn.com - June 22 at 5:30 PM
nz.finance.yahoo.com logoSL Green Announces Sale of 609 Fifth Avenue
nz.finance.yahoo.com - June 6 at 7:37 AM
seekingalpha.com logoAbeona adds new CFO from Avenue Therapeutics
seekingalpha.com - March 10 at 9:06 AM
seekingalpha.com logoAvenue Therapeutics trebles in value on rising volume
seekingalpha.com - March 1 at 5:42 PM
msn.com logoThe Daily Biotech Pulse: Avenue Tumbles On Negative Adcom Verdict, Moderna's Expanded Deal With Rovi, Gilead Takes Equity Stake In Hookipa
msn.com - February 16 at 10:56 AM
msn.com logoFDA's AdComm Says Avenue Therapeutics Submitted Insufficient Data On IV Tramadol
msn.com - February 16 at 10:56 AM
seekingalpha.com logoAvenue Therapeutics gets FDA panel's rejection on IV pain drug
seekingalpha.com - February 16 at 10:56 AM
finance.yahoo.com logoAvenue Therapeutics Announces Outcome of FDA Advisory Committee Meeting on IV Tramadol
finance.yahoo.com - February 16 at 12:31 AM
marketwatch.com logoAvenue Therapeutics Trading Halted Ahead of FDA Advisory Committee Meeting
marketwatch.com - February 15 at 7:31 PM
msn.com logoThe Daily Biotech Pulse: Larimar Plunges On Extension Of Clinical Hold, ImmunityBio Gains On Positive Data, Adcom Test Awaits Avenue Therapeutics
msn.com - February 15 at 9:30 AM
finance.yahoo.com logoAvenue Therapeutics Stock Trading Halted Today
finance.yahoo.com - February 15 at 9:30 AM
seekingalpha.com logoAvenue Therapeutics IV pain therapy to go under FDA review amid safety concerns
seekingalpha.com - February 11 at 6:36 PM
nasdaq.com logoAvenue Therapeutics, Inc. Common Stock (ATXI)
nasdaq.com - January 23 at 8:13 PM
nasdaq.com logoAvenue Therapeutics Inc Shares Fall 2.4% Below Previous 52-Week Low - Market Mover
nasdaq.com - January 11 at 3:00 AM
nasdaq.com logoAvenue Therapeutics Inc Shares Near 52-Week Low - Market Mover
nasdaq.com - January 8 at 12:26 AM
nasdaq.com logoAvenue Therapeutics Inc Shares Close in on 52-Week Low - Market Mover
nasdaq.com - December 31 at 10:18 AM
finance.yahoo.com logoAegis Capital Corp. Acted as Sole Bookrunner on a $2 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ: ATXI)
finance.yahoo.com - December 15 at 5:32 PM
finance.yahoo.com logoAvenue Therapeutics Prices $2.0 Million Underwritten Public Offering of Common Stock
finance.yahoo.com - December 12 at 11:57 PM
finance.yahoo.com logoAvenue Therapeutics Announces FDA Advisory Committee Meeting to Review IV Tramadol NDA Tentatively Scheduled for February 15, 2022
finance.yahoo.com - November 29 at 10:19 AM
finance.yahoo.com logoAvenue Therapeutics Announces Closing of Public Offering of Common Stock
finance.yahoo.com - November 12 at 11:20 AM
finance.yahoo.com logoAegis Capital Corp. acted as Sole Bookrunner on a $2.6 Million Public Offering of Common Stock for Avenue Therapeutics (NASDAQ: ATXI)
finance.yahoo.com - November 12 at 11:20 AM
marketwatch.com logoAvenue Therapeutics Shares Rise as FDA Panel to Meet on Appeal >ATXI
marketwatch.com - October 25 at 5:10 PM
finance.yahoo.com logoAvenue Therapeutics Receives Interim Response to its Formal Dispute Resolution Request from U.S. Food and Drug Administration Office of New Drugs
finance.yahoo.com - October 25 at 7:08 AM
msn.com logoDouglas Avenue In Flossmoor Closed Early Next Week: Village
msn.com - October 1 at 6:37 PM
msn.com logoAvenue Capital's Marc Lasry resigns from Ozy Media chairman role
msn.com - September 30 at 6:43 PM
msn.com logoParts Of Mountain Avenue Closed For Milling, Paving Project
msn.com - September 30 at 1:02 PM
msn.com logo3 hospitalized from multi-car crash on Colerain Avenue
msn.com - September 27 at 10:31 PM
bizjournals.com logoRedevelopment plans released for Second Avenue buildings
bizjournals.com - September 27 at 5:31 PM
msn.com logoMan shot near Union Avenue in Providence
msn.com - September 26 at 12:54 PM
msn.com logoAvenue Q Walmart robbed, suspect in custody
msn.com - September 25 at 3:13 PM
msn.com logoMan In Mattapan Dies After Stabbing In Area Of Blue Hill Avenue And Columbia Road
msn.com - August 29 at 2:15 AM
msn.com logoMan In Dorchester Dies After Stabbing In Area Of Blue Hill Avenue And Columbia Road
msn.com - August 29 at 2:15 AM
finance.yahoo.com logoAmneal (AMRX) Parkinson's Candidate Successful in Pivotal Study
finance.yahoo.com - August 26 at 3:33 PM
msn.com logoGas leak prompts evacuations in San Jose near Race Street and Park Avenue
msn.com - August 25 at 11:04 PM
Get Avenue Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for ATXI and its competitors with MarketBeat's FREE daily newsletter.

This page (NASDAQ:ATXI) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.